Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic

NATerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

July 20, 2021

Primary Completion Date

October 19, 2021

Study Completion Date

October 19, 2021

Conditions
Chronic Obstructive Pulmonary DiseaseChronic CoughCovid19
Interventions
DEVICE

HCFWO

The Afflovest device is a High Frequency Chest Wall Oscillation (HFCWO) device, a medical vest that uses vibrations to loosen and mobilize mucus in the lung secretions and help clear the airways.

OTHER

Standard Care Plus Monitoring

Monitoring via home spirometry, pulse oximetry, temperature checks, telehealth check-in and patient-reported outcome assessments.

Trial Locations (1)

10003

Mount Sinai Beth Israel, New York

Sponsors
All Listed Sponsors
collaborator

International Biophysics Corporation

INDUSTRY

collaborator

SPARK Healthcare

UNKNOWN

lead

Icahn School of Medicine at Mount Sinai

OTHER